IP Library Assignment 041887/0117
Patent Assignment
Reel/Frame 041887/0117

Assignment of Assignor's Interest

Recorded: 2017-04-06 Pages: 8
Assignor
BIOGEN MA INC.
Executed: 2017-04-04
Assignee
GLORIANA THERAPEUTICS SARL
AVENUE DU SECHERON 15, GENEVE, 1202, SWITZERLAND
Covered Properties (19)
Novel Neurotrophic Factors
Patent: 6,593,133 →
Application: 09/347,613 →
Polymer Conjugates of Mutated Neublastin
Patent: 7,442,370 →
Application: 10/356,264 →
Publication: US 2005/0142098
Polymer-Conjugated Glycosylated Neublastin
Patent: 8,163,875 →
Application: 10/553,710 →
Publication: US 2007/0238650
Novel Neurotrophic Factors
Patent: 7,276,580 →
Application: 10/661,984 →
Publication: US 2004/0142418
Neublastin Expression Constructs
Patent: 7,598,059 →
Application: 10/957,221 →
Publication: US 2005/0158824
Refolding Transforming Growth Factor Beta Family Proteins
Patent: 8,722,862 →
Application: 11/573,771 →
Publication: US 2008/0249287
Neublastin Variants
Patent: 8,263,553 →
Application: 11/573,773 →
Publication: US 2008/0039385
Methods of Treating Pain Using Neurotrophic Factors
Patent: 7,358,228 →
Application: 11/614,599 →
Publication: US 2007/0099270
Methods of Activating Ret Receptor Tyrosine Kinase Using Neurotrophic Factors
Patent: 7,655,463 →
Application: 12/029,917 →
Publication: US 2008/0233647
Polymer Conjugates of Mutated Neublastin
Patent: 8,119,114 →
Application: 12/163,425 →
Publication: US 2008/0306212
Treatments for Neurological Disorders
Application: 12/280,772 →
Publication: US 2009/0221495
Compositions and Methods for Administering Gdnf Ligand Family Proteins
Application: 12/281,077 →
Publication: US 2010/0056440
Methods for Increasing Vascularization
Patent: 8,329,655 →
Application: 12/598,293 →
Publication: US 2010/0261654
Neurotrophic Factors and Methods of Use Thereof
Patent: 8,217,146 →
Application: 12/632,517 →
Publication: US 2010/0292142
Polymer-Conjugated Glycosylated Neublastin
Patent: 8,642,732 →
Application: 13/425,583 →
Publication: US 2012/0316109
Compositions and Methods for Increasing Vascularization
Patent: 9,138,461 →
Application: 13/679,529 →
Publication: US 2013/0237477
Anti-Neublastin Antibodies and Uses Thereof
Application: 14/589,372 →
Publication: US 2015/0344550
Medium Supplements for Improved Process Performance
Application: 14/760,182 →
Publication: US 2015/0353883
Medium Supplements for Improved Process Performance
Application: 15/291,257 →
Publication: US 2017/0029859
Related Assignments (16)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 9, 2008
From: SAH, DINAH WEN-YEE; PEPINSKY, R. BLAKE; BORIACK-SJODIN, PAULA ANN; MILLER, STEPHAN S.
To: BIOGEN, INC.
Reel/Frame 021504/0960 →
Change of Name Sep 12, 2008
From: BIOGEN, INC.
To: BIOGEN IDEC MA INC.
Reel/Frame 021522/0679 →
Assignment of Assignor's Interest Dec 14, 2009
From: ROSSOMANDO, ANTHONY; PEPINSKY, R. BLAKE
To: BIOGEN IDEC MA INC.
Reel/Frame 023650/0295 →
Assignment of Assignor's Interest Jan 14, 2010
From: SAH, DINAH W.Y.; ROSSOMANDO, ANTHONY
To: BIOGEN IDEC MA INC.
Reel/Frame 023784/0518 →
Assignment of Assignor's Interest Jan 14, 2010
From: JOHANSEN, TEIT E.
To: NSGENE A/S
Reel/Frame 023784/0590 →
Assignment of Assignor's Interest Jan 31, 2011
From: ROSSOMANDO, ANTHONY
To: BIOGEN IDEC MA INC.
Reel/Frame 025719/0689 →
Assignment of Assignor's Interest May 9, 2011
From: SILVESTRE, JEAN-SEBASTIEN; TAMARAT, RADIA
To: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
Reel/Frame 026245/0128 →
Assignment of Assignor's Interest Jun 17, 2013
From: SAH, DINAH WEN-YEE; PEPINSKY, R. BLAKE; ROSSOMANDO, ANTHONY
To: BIOGEN IDEC MA INC.
Reel/Frame 030624/0899 →
Assignment of Assignor's Interest Sep 17, 2013
From: SILVESTRE, JEAN-SEBASTIEN; TAMARAT, RADIA
To: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
Reel/Frame 031224/0363 →
Assignment of Assignor's Interest Sep 17, 2013
From: ROSSOMANDO, ANTHONY
To: BIOGEN IDEC MA INC.
Reel/Frame 031224/0341 →
Assignment of Assignor's Interest Jan 8, 2015
From: ROSSOMANDO, ANTHONY; JIN, PING
To: BIOGEN IDEC MA INC.
Reel/Frame 034668/0043 →
Change of Name May 4, 2015
From: BIOGEN IDEC MA INC.
To: BIOGEN MA INC.
Reel/Frame 035571/0926 →
Assignment of Assignor's Interest Nov 11, 2015
From: GILBERT, ALAN; MCELEARNEY, KYLE; DOBROWSKY, TERRENCE MICHAEL; KSHIRSAGAR, RASHMI ROHIT
To: BIOGEN MA INC.
Reel/Frame 037006/0839 →
Assignment of Assignor's Interest Apr 26, 2019
From: GLORIANA THERAPEUTICS SARL
To: GLORIANA THERAPEUTICS, INC.
Reel/Frame 049005/0877 →
Assignment of Assignor's Interest Aug 3, 2022
From: GLORIANA THERAPEUTICS, INC.
To: SINFONIA BIOTHERAPEUTICS AB
Reel/Frame 060711/0374 →
Assignment of Assignor's Interest Jan 5, 2023
From: GLORIANA THERAPEUTICS
To: SINFONIA BIOTHERAPEUTICS AB
Reel/Frame 062287/0670 →